Connect your AI

Pulse Biosciences, Inc. PLSE Inventories

Inventories at other companies

AbbottABT

$6.99B+5.3%

Johnson & JohnsonJNJ

$14.58B+15.2%

Boston ScientificBSX

$3.12B+8.7%

AtriCureATRC

$81.14M+8.3%

MedtronicMDT

$5.95B+8.7%

Merit Medical SystemsMMSI

$352.39M+10.8%

Other financials

Income statement

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

Market cap$1.77B+38.4%

Profitability

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pulse Biosciences, Inc.'s inventories?: Pulse Biosciences, Inc. (PLSE) reported inventories of $206K in Q1 2026.
How has Pulse Biosciences, Inc.'s inventories changed year-over-year?: Pulse Biosciences, Inc.'s inventories increased by 586.7% year-over-year, from $30K to $206K.
What is the long-term trend for Pulse Biosciences, Inc.'s inventories?: Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s inventories has grown at a -62.6% compound annual growth rate (CAGR), from $13.93M to $274K.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.